Navidea Biopharmaceuticals (NAVB)

Add to Watchlists Create an Alert
2.495 +0.10  +3.96%   AMEX May 23, 4:59PM BATS Real time Currency in USD

Navidea Biopharmaceuticals Return on Assets:

-143.6% for Dec. 31, 2012
View Full Chart

Navidea Biopharmaceuticals Return on Assets Chart

    Navidea Biopharmaceuticals Historical Return on Assets Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -143.6%
    Sept. 30, 2012 -120.1%
    June 30, 2012 -2.47%
    March 31, 2012 13.23%
    Dec. 31, 2011 27.71%
    Sept. 30, 2011 72.44%
    June 30, 2011 -107.0%
    March 31, 2011 -531.2%
    Dec. 31, 2010 -567.5%
    Sept. 30, 2010 -568.8%
    June 30, 2010 -813.9%
    March 31, 2010 -479.7%
    Dec. 31, 2009 -439.6%
    Sept. 30, 2009 -467.3%
    June 30, 2009 -204.4%
    March 31, 2009 -40.71%
    Dec. 31, 2008 -66.49%
    Sept. 30, 2008 -82.71%
    June 30, 2008 -71.84%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Return on Assets

    Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.

    Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.

    Learn More

    Get data for

    NAVB Return on Assets Benchmarks

    Companies
    Abiomed 9.27%
    Guided Therapeutics -113.6%
    Span-America Medical 13.32%

    NAVB Return on Assets Rankings

    Overall 39th percentile
    4822 of 8006
    Sector 19th percentile
    549 of 686 in Healthcare
    Industry 17th percentile
    77 of 93 in Medical Devices

    NAVB Return on Assets Range, Past 5 Years

    Minimum -813.9% Jun 2010
    Maximum 72.44% Sep 2011
    Average -241.8%